Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Using index level provides a macro view of market direction, helping you balance stock-specific decisions with overall sentiment.
27,685 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Chipotle’s stock rebound from a recent malaise is taking shape as pricing discipline and menu changes attract more di...
Macy’s stock surged after the retailer posted a third straight quarter of rising comparable sales, surpassing expecta...
A Manhattan class-action accuses Gemini of misrepresenting its growth plan during its September IPO. Shares have fall...
Micron's memory leadership and AI-ready HBM4 shipments clash with Intel's restructuring effort and foundry bets. As A...
Johnson & Johnson and Coca-Cola posted strong Q1 2026 results as markets rotate toward defensive plays. The big quest...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...
Stocks moved higher after a choppy morning, with broad participation lifting the S&P 500 and SPY. Traders are weighin...
Broadcom is edging toward a 52-week peak as AI demand fuels revenue growth and capital returns. Analysts weigh buy, h...
SpaceX briefly cleared the $200 level before retreating, sparking renewed debate over whether the stock is a standalo...
Altria's pricing power has shifted the stock into a retirement fortress, delivering durable cash flow and a high-yiel...
Dell is closing in on its 52-week high as AI server demand lifts results, prompting investors to weigh whether to buy...